인쇄하기
취소

Pharmaceutical patent issue seen as a key FTA agenda

Published: 2007-02-14 07:00:00
Updated: 2007-02-14 07:00:00
The pharmaceutical patent issues will be resurfaced on the Korea and U.S. free trade agreement (FTA) as a key agenda.

In the seventh round of the FTA talks in Washington DC, the U.S. side will call for their patents to be linked with the health registration of new drugs, while seeking generic drug approvals to be under control within the valid terms of its patent protection.

So far, the ...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.